US EditionEurofins Viracor Revolutionizes Respiratory Diagnostics with New BAL Specimen Type for NeXGen® Fungal / AFB NGS Assay
- On May 7, 2025, Eurofins Viracor in Lenexa, Kansas, announced a new BAL specimen type for its NeXGen Fungal / AFB NGS assay.
- This launch addresses the limitations of traditional culture methods, which are time-consuming and may miss slow-growing or atypical pathogens.
- The assay leverages Next Generation Sequencing to accurately detect hundreds of fungal and AFB species from BAL samples, including uncommon or unusual pathogens.
- The assay offers significantly faster turnaround times than cultures and supports earlier therapy initiation, which may reduce morbidity and mortality.
- Eurofins Viracor's innovation exemplifies its and parent company Eurofins Scientific's commitment to advancing infectious disease diagnostics worldwide.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
All
Left
1
Center
2
Right
Farm Talk Newspaper+10 Reposted by 10 other sources
Eurofins Viracor Revolutionizes Respiratory Diagnostics with New BAL Specimen Type for NeXGen® Fungal / AFB NGS Assay
LENEXA, Kan., May 7, 2025 /PRNewswire/ -- Eurofins Viracor, a leading specialty diagnostics laboratory, is proud to announce a groundbreaking advancement in respiratory infection diagnostics with the launch of a new bronchoalveolar lavage (BAL) specimen type for its NeXGen® Fungal…
·Parsons, United States
Read Full ArticleCoverage Details
Total News Sources11
Leaning Left1Leaning Right0Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
